Holen Sie sich die Stockscreener-App
161.84
3.60%
-6.06
Handel nachbörslich:
162.00
0.16
+0.10%
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
What Makes IQVIA Holdings (IQV) an Investment Bet? - Insider Monkey
IQVIA Holdings, Inc. (IQV): Analyst Consensus Reveals 36% Upside Potential for Healthcare Giant - DirectorsTalk Interviews
Liquidity Mapping Around (IQV) Price Events - Stock Traders Daily
IQVIA signals raised 2026 adjusted EPS outlook to $12.65-$12.95 while reaffirming $17.150B-$17.350B revenue - MSN
Are Wall Street analysts predicting IQVIA Holdings stock will climb or sink? - MSN
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IQVIA Holdings Inc stock (US46266C1053): data-driven healthcare group in focus after latest earnings - AD HOC NEWS
Are Wall Street Analysts Predicting IQVIA Holdings Stock Will Climb or Sink? - Barchart.com
IQVIA’s SWOT analysis: healthcare stock faces margin pressures - Investing.com
IQVIA: The Market May Be Missing The AI And Data Story (NYSE:IQV) - Seeking Alpha
Research Alert: CFRA Moderates Rating On Shares Of Iqvia Holdings Inc. To Hold From Buy - Moomoo
IQVIA Holdings stock (US46266C1053): latest earnings highlight data strength and AI ambitions - AD HOC NEWS
IQVIA Signals Confidence with $3.2 Billion Share Repurchase War Chest - BriefGlance
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA (IQV) Fell Despite Strong Fundamentals - Insider Monkey
IQVIA Holdings, Inc. (IQV) Stock Analysis: Growth Potential and Analyst Consensus Point to 35% Upside - DirectorsTalk Interviews
Mid-Cap Stocks: IQVIA (IQV) and First Citizens (FCNCA) Sell SignalsNews and Statistics - IndexBox
IQVIA Holdings (IQV) Q1 earnings and revenues beat estimates - MSN
IQVIA Holdings stock (US46266C1053): earnings, data growth and what investors watch now - AD HOC NEWS
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know - Yahoo Finance
IQVIA Holdings Inc stock (US46266C1053): earnings momentum and AI narrative draw fresh attention - AD HOC NEWS
Catholic Responsible Investments Equity Index Fund's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
Is There Now An Opportunity In IQVIA Holdings Inc. (NYSE:IQV)? - Moomoo
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BeOne Medicines (ONC) and Nektar Therapeutics (NKTR) - The Globe and Mail
Will IQVIA's (IQV) AI‑Driven Biosimilar Partnership with Kexing Reshape Its Long‑Term Narrative? - Yahoo Finance
IQVIA’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
IQVIA Holdings earnings preview: What to expect - MSN
BofA Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $245 - Moomoo
IQVIA Holdings stock (US46266C1053): Expands AI-powered biosimilars deal with Kexing Biopharm - AD HOC NEWS
IQVIA Holdings, Inc. Common Stock (NY: IQV - FinancialContent
IQVIA expands collaboration with Kexing Biopharm on biosimilars - Investing.com UK
Why (IQV) Price Action Is Critical for Tactical Trading - Stock Traders Daily
IQVIA expands collaboration with Kexing Biopharm on biosimilars By Investing.com - Investing.com Nigeria
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
AI-powered trials to speed global biosimilar drugs in IQVIA-Kexing pact - Stock Titan
IQVIA Holdings stock (US46266C1053): Global leader in healthcare data analytics - AD HOC NEWS
IQVIA Q1 2026 slides: earnings beat drives guidance raise By Investing.com - Investing.com Nigeria
IQVIA Q1 2026 slides: earnings beat drives guidance raise - Investing.com
Earnings call transcript: IQVIA surpasses Q1 2026 forecasts, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: IQVIA surpasses Q1 2026 forecasts, stock surges - Investing.com
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance
IQVIA Holdings | 4: Statement of changes in beneficial ownership of securities-Director GOGGINS COLLEEN A - Moomoo
IQVIA (NYSE: IQV) director granted 171 deferred shares at $178.64 - Stock Titan
IQVIA (NYSE: IQV) director Colleen Goggins receives 214 Deferred Shares grant - Stock Titan
IQVIA (NYSE: IQV) director Jim Fasano receives 228 deferred share award - Stock Titan
IQVIA (NYSE: IQV) director awarded 185 deferred shares with 1:1 common conversion - Stock Titan
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why is Larry Robbins Bullish on IQVIA Holdings (IQV) Amid Market Volatility - Kavout
IQVIA Holdings Inc. (IQV): Larry Robbins Is Bullish on This Stock - Insider Monkey
Why IQVIA Holdings (IQV) Is Up 12.8% After Q1 Beat and Bigger Buyback Plan – And What's Next - Sahm
Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China - GlobeNewswire Inc.
IQVIA Holdings, Inc. (IQV) Stock Analysis: Robust Growth Potential With A 27.92% Upside - DirectorsTalk Interviews
IQVIA Q1 Earnings Call Highlights - sharewise.com
1.17%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):